5-amino-1mq nnmt inhibitor study Nicotinamide N-Methyltransferase in Cardiovascular Diseases: Metabolic Regulator and Emerging Therapeutic Target 5-Amino-1MQ: Benefits and Research Insights

For the beta diversity analyses, an analysis of similarities (ANOSIM) was performed on each of the distance/dissimilarity matrices to establish whether observed clustering by treatment group was statistically significant

Results demonstrated that AOD-9604 displayed a very good safety and tolerability profile indistinguishable from placebo. Critically, the peptide produced no clinically significant alterations in IGF-1 levels, no glucose intolerance or insulin resistance, and no anti-AOD9604 antibodies in any participant

It is a small synthetic molecule that blocks an enzyme called NNMT (nicotinamide N-methyltransferase)

Appropriate use is determined individually by a licensed medical provider based on your health profile, and it requires a prescription and clinical oversight

This, in turn, will aid inflammation and weight loss